Literature DB >> 5501902

Evaluation of possible chronic hepatotoxicity from methotrexate for psoriasis.

G D Weinstein, J W Cox, D W Suringa, M M Millard, M Kalser, P Frost.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5501902

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN： 0003-987X


× No keyword cloud information.
  4 in total

1.  Methotrexate hepatotoxicity in psoriasis--comparison of different dose regimens.

Authors:  M G Dahl; M M Gregory; P J Scheuer
Journal:  Br Med J       Date:  1972-03-11

2.  Low incidence of hepatotoxicity associated with long-term, low-dose oral methotrexate in treatment of refractory psoriasis, psoriatic arthritis, and rheumatoid arthritis. An acceptable risk/benefit ratio.

Authors:  S B Lanse; G L Arnold; J D Gowans; M M Kaplan
Journal:  Dig Dis Sci       Date:  1985-02       Impact factor: 3.199

3.  Chemotherapy induced liver abnormalities: an imaging perspective.

Authors:  Ankush Sharma; Roozbeh Houshyar; Priya Bhosale; Joon-Il Choi; Rajesh Gulati; Chandana Lall
Journal:  Clin Mol Hepatol       Date:  2014-09

4.  Quantifying the hepatotoxic risk of alcohol consumption in patients with rheumatoid arthritis taking methotrexate.

Authors:  Jenny H Humphreys; Alexander Warner; Ruth Costello; Mark Lunt; Suzanne M M Verstappen; William G Dixon
Journal:  Ann Rheum Dis       Date:  2017-03-23       Impact factor: 19.103
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.